Abstract
The use of interferon beta-1a to treat multiple sclerosis in a child of 7 years of age is discussed. To date, there is only one other published report of the use of interferon beta in a child as young as this. One year after commencing treatment she had shown significant clinical improvement, with a marked reduction in number of relapses. In her second year of treatment she suffered a major relapse from which she slowly recovered.
MeSH terms
-
Adjuvants, Immunologic / therapeutic use*
-
Brain / pathology
-
Child
-
Female
-
Glucocorticoids / therapeutic use
-
Humans
-
Interferon beta-1a
-
Interferon-beta / therapeutic use*
-
Magnetic Resonance Imaging
-
Methylprednisolone / therapeutic use
-
Multiple Sclerosis / drug therapy*
-
Multiple Sclerosis / pathology
-
Recurrence
-
Treatment Outcome
Substances
-
Adjuvants, Immunologic
-
Glucocorticoids
-
Interferon-beta
-
Methylprednisolone
-
Interferon beta-1a